| Alzheimer Disease |
1 |
1 |
| Brain |
0 |
0.7 |
| Patient Safety |
0 |
0.51 |
| Care and Maintenance of Vision |
0 |
0.41 |
| Cataract |
0 |
0.41 |
| Adverse Effects |
0 |
0.39 |
| Mild Cognitive Impairment |
0 |
0.38 |
| Cognitive Impairment |
0 |
0.33 |
| A-Scan Biometry |
0 |
0.31 |
| Scan |
0 |
0.31 |
| Dementia |
0 |
0.23 |
| Impairment |
0 |
0.23 |
| Medicare |
0 |
0.23 |
| Genomic Medicine |
0 |
0.17 |
| Genetic Testing |
0 |
0.11 |
| Social Determinants of Health |
0 |
0.1 |
| Tropical Diseases |
0 |
0.1 |
| Wound Management |
0 |
0.1 |
| Biomarker |
0 |
0.08 |
| Blood |
0 |
0.08 |
| Cerebrospinal Fluid |
0 |
0.08 |
| Cognition |
0 |
0.08 |
| Disease-Modifying Therapy |
0 |
0.08 |
| Genetics |
0 |
0.08 |
| Hand |
0 |
0.08 |
| Health Care Economics |
0 |
0.08 |
| Injury |
0 |
0.08 |
| Memory |
0 |
0.08 |
| Neuroimaging |
0 |
0.08 |
| Plague |
0 |
0.08 |
| Primary Care |
0 |
0.08 |